Celery seed trial reports within-group changes, leaving placebo advantage unclear
Blood pressure and several blood markers fell in the celery seed group, but the abstract does not report the corresponding between-group effects.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The celery seed group had lower blood pressure and several blood-marker measurements at the end of the trial than at baseline. Insulin sensitivity and insulin secretion did not show statistically significant changes. Because the abstract does not present the corresponding placebo comparisons, these results cannot establish that celery seed caused the improvements.
Although placebo controlled, the trial's abstract lists within-group changes without between-group estimates or confidence intervals. That limits what this abstract-based summary can conclude about efficacy.
What researchers found
Systolic blood pressure in the celery seed group
Baseline versus the end of 12 weeks; p = 0.005. These are within-group values, with the meaning of the ± figures unspecified in the abstract.
Other measured changes
Changes in triglycerides, very low-density lipoprotein and uric acid accompanied the blood-pressure findings. These are laboratory measurements, and the abstract reports no evidence about cardiovascular events or other clinical outcomes.
Insulin outcomes remained uncertain
Insulin sensitivity and secretion were part of the study's question, yet neither showed a statistically significant change within the celery seed group. This leaves their effects uncertain rather than proving no effect.
The original publication
Effect of Celery Seed (Apium graveolens L.) Administration on the Components of Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion: A Clinical Trial.
Escobedo-Gutiérrez MJ, Cortez-Navarrete M, Martínez-Abundis E et al.
Pharmaceuticals (Basel) · 2026
- PubMed ID
- 41599709
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.